Invention Grant
- Patent Title: DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
-
Application No.: US15403705Application Date: 2017-01-11
-
Publication No.: US10022379B2Publication Date: 2018-07-17
- Inventor: Thomas Friedl , Michael Braun , Kenji Egusa , Hikaru Fujita , Megumi Maruyama , Takaaki Nishioka
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Marc Began; David L. Kershner
- Priority: EP08154039 20080403
- Main IPC: A61K31/522
- IPC: A61K31/522 ; A61K9/00 ; A61K31/155 ; A61K9/20 ; A61K9/28 ; A61K9/24
Abstract:
The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
Public/Granted literature
Information query
IPC分类:
